Krystal Biotech, Inc. KRYS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s operating lease ROU assets?
- Krystal Biotech, Inc. (KRYS) reported operating lease ROU assets of 9.7% in Q1 2026.
- How has Krystal Biotech, Inc.'s operating lease ROU assets changed year-over-year?
- Krystal Biotech, Inc.'s operating lease ROU assets increased by 1.0% year-over-year, from 9.6% to 9.7%.
- What is the long-term trend for Krystal Biotech, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s operating lease ROU assets has grown at a -96.9% compound annual growth rate (CAGR), from 329,800,000% to 9.7%.
- What does operating lease ROU assets mean?
- The value of the right to use leased assets like offices or labs.
- How do you interpret operating lease ROU assets?
- An increase indicates expanded facility commitments, while a decrease suggests the expiration or reduction of lease obligations.
- How does operating lease ROU assets compare across companies?
- Standardized under modern accounting rules; comparable across all companies with significant real estate or equipment lease footprints.